Tauopathy in the periaqueductal gray, kölliker-fuse nucleus and nucleus retroambiguus is not predicted by ultrasonic vocalization in tau-P301L mice.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 11 12 2018
revised: 15 04 2019
accepted: 15 04 2019
pubmed: 21 4 2019
medline: 24 6 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

Upper airway and vocalization control areas such as the periaqueductal gray (PAG), kölliker-fuse nucleus (KF) and nucleus retroambiguus (NRA) are prone to developing tauopathy in mice expressing the mutant human tau P301L protein. Consequently, impaired ultrasonic vocalization (USV) previously identified in tau-P301L mice at the terminal disease stage of 8-9 months of age, was attributed to the presence of tauopathy in these regions. Our aim was to establish whether the onset of USV disorders manifest prior to the terminal stage, and if USV disorders are predictive of the presence of tauopathy in the PAG, KF and NRA. USVs produced by tau-P301L and wildtype mice aged 3-4, 5-6 or 8-9 months were recorded during male-female interaction. Immunohistochemistry was then performed to assess the presence or degree of tauopathy in the PAG, KF and NRA of mice displaying normal or abnormal USV patterns. Comparing various USV measurements, including the number, duration and frequency of calls, revealed no differences between tau-P301L and wildtype mice across all age groups, and linear discriminant analysis also failed to identify separate USV populations. Finally, the presence of tauopathy in the PAG, KF and NRA in individual tau-P301L mice did not reliably associate with USV disorders. Our findings that tauopathy in designated mammalian vocalization centres, such as the PAG, KF and NRA, did not associate with USV disturbances in tau-P301L mice questions whether USV phenotypes in this transgenic mouse are valid for studying tauopathy-related human voice and speech disorders.

Identifiants

pubmed: 31004684
pii: S0166-4328(18)31726-1
doi: 10.1016/j.bbr.2019.111916
pii:
doi:

Substances chimiques

tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111916

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Pedro Trevizan-Baú (P)

The Florey Institute of Neuroscience and Mental Health, Discovery Neuroscience Theme, Australia.

Rishi R Dhingra (RR)

The Florey Institute of Neuroscience and Mental Health, Discovery Neuroscience Theme, Australia.

Emma L Burrows (EL)

Mental Health Theme, University of Melbourne, Parkville, Victoria, 3010, Australia.

Mathias Dutschmann (M)

The Florey Institute of Neuroscience and Mental Health, Discovery Neuroscience Theme, Australia. Electronic address: mathias.dutschmann@florey.edu.au.

Davor Stanić (D)

The Florey Institute of Neuroscience and Mental Health, Discovery Neuroscience Theme, Australia. Electronic address: davor.stanic@florey.edu.au.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH